Share
Market Research Report

MACULAR DEGENERATION TREATMENT MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Segmentation
  • By TypeDry Age-related Macular Degeneration and Wet Age-related Macular Degeneration
  • By Stage Of DiseaseEarly-stage AMD · Intermediate AMD · Late-stage AMD
  • By Route Of AdministrationIntravenous Route and Intravitreal Route
  • By Sales ChannelAmbulatory Surgical Centres · Hospitals · and Other Sales Channels
  • By GeographyNorth America · Europe · Asia-Pacific · Latin America · and Middle East & Africa
  • Published In18 Mar 2026
  • Report CodeCMI5149
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026 - 2033

Market Segmentation

  • By Type

    • Dry Age-related Macular Degeneration
    • Wet Age-related Macular Degeneration
  • By Stage Of Disease

    • Early-stage AMD
    • Intermediate AMD
    • Late-stage AMD
  • By Route Of Administration

    • Intravenous Route
    • Intravitreal Route
  • By Sales Channel

    • Ambulatory Surgical Centres
    • Hospitals
    • Other Sales Channels
  • By Regional Insights

    • North America
      • U.S.
      • Canada
    • Latin America
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
    • Europe
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • GCC Countries
      • Israel
      • Rest of Middle East
    • Africa
      • South Africa
      • North Africa
      • Central Africa